Nephros, Inc. (NEPH)
NASDAQ: NEPH · IEX Real-Time Price · USD
2.350
+0.240 (11.37%)
Jul 22, 2024, 9:44 AM EDT - Market open
Nephros Employees
Nephros had 31 employees as of December 31, 2023. The number of employees increased by 4 or 14.81% compared to the previous year.
Employees
31
Change (1Y)
4
Growth (1Y)
14.81%
Revenue / Employee
$453,645
Profits / Employee
-$46,387
Market Cap
23.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ImmunoPrecise Antibodies | 102 |
Ekso Bionics Holdings | 72 |
HCW Biologics | 45 |
Apollomics | 45 |
Inspira Technologies Oxy B.H.N. | 42 |
Sol-Gel Technologies | 36 |
Gain Therapeutics | 32 |
BioVie | 18 |
NEPH News
- 4 months ago - Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results - GlobeNewsWire
- 5 months ago - Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results - GlobeNewsWire
- 9 months ago - Nephros Announces Results for Quarter Ended September 30, 2023 - GlobeNewsWire
- 9 months ago - Nephros Hires Judy Krandel as Chief Financial Officer - GlobeNewsWire
- 9 months ago - Nephros Schedules Third Quarter 2023 Financial Results Conference Call - GlobeNewsWire
- 10 months ago - Nephros to Present at LD Micro Main Event XVI - Newsfile Corp
- 1 year ago - Nephros Announces Results for Quarter Ended June 30, 2023 - GlobeNewsWire
- 1 year ago - Nephros Schedules Second Quarter 2023 Financial Results Conference Call - GlobeNewsWire